Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer have?
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer has 9 citations in the OpenAlex counts ScholarIQ stores.
When was Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer published?
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer has 2024 year in the ScholarIQ index.
What is the open-access status of Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer?
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer has hybrid oa status in the ScholarIQ index.
What is the DOI of Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer?
The DOI for Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer is on the source record.
What is the PMID of Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer?
The PMID for Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer is on the source record.
What is the OpenAlex record for Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer?
The OpenAlex for Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer is on the source record.